Kevin Koch

2013

In 2013, Kevin Koch earned a total compensation of $1.1M as President and Chief Scientific Officer at Array BioPharma, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$215,380
Option Awards$361,698
Salary$445,000
Other$36,415
Total$1,058,493

Koch received $445K in salary, accounting for 42% of the total pay in 2013.

Koch also received $215.4K in non-equity incentive plan, $361.7K in option awards and $36.4K in other compensation.

Rankings

In 2013, Kevin Koch's compensation ranked 6,347th out of 12,286 executives tracked by ExecPay. In other words, Koch earned more than 48.3% of executives.

ClassificationRankingPercentile
All
6,347
out of 12,286
48th
Division
Manufacturing
2,224
out of 4,612
52nd
Major group
Chemicals And Allied Products
660
out of 1,462
55th
Industry group
Drugs
478
out of 1,156
59th
Industry
Pharmaceutical Preparations
381
out of 890
57th
Source: SEC filing on September 13, 2013.

Koch's colleagues

We found seven more compensation records of executives who worked with Kevin Koch at Array BioPharma in 2013.

2013

Ron Squarer

Array BioPharma

Chief Executive Officer

2013

Ron Chief

Array BioPharma

Executive Officer

2013

Andrew Robbins

Array BioPharma

Chief Operating Officer

2013

Michael Needle

Array BioPharma

Chief Medical Officer

2013

David Snitman

Array BioPharma

Chief Operating Officer

2013

R Carruthers

Array BioPharma

Chief Financial Officer

2013

John Moore

Array BioPharma

General Counsel

You may also like